Cargando…
IL-1 SRS Without the Bunker: Introduction and Clinical Experience of ZAP-X Gyroscopic Radiosurgery
Each year more than two million patients worldwide are potential candidates for SRS, yet due to the significant costs and complexities of historical delivery systems, only 150,000 patients currently receive such treatment. Japan Shonin-cleared in 2020, ZAP Surgical’s ZAP-X Gyroscopic Radiosurgery pl...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648181/ http://dx.doi.org/10.1093/noajnl/vdab159.000 |
_version_ | 1784610750720901120 |
---|---|
author | Adler, John R |
author_facet | Adler, John R |
author_sort | Adler, John R |
collection | PubMed |
description | Each year more than two million patients worldwide are potential candidates for SRS, yet due to the significant costs and complexities of historical delivery systems, only 150,000 patients currently receive such treatment. Japan Shonin-cleared in 2020, ZAP Surgical’s ZAP-X Gyroscopic Radiosurgery platform was designed to solve this challenge, and ultimately bring world-class SRS to more patients in more places. ZAP-X is recognized for being the first and only vault-free SRS delivery system, thereby typically eliminating the need for providers to build costly shielded radiation treatment rooms. Utilizing a modern linear accelerator to produce radiation, ZAP-X is also the first and only dedicated radiosurgery system to no longer require Cobalt-60 radioactive sources, thereby eliminating the significant costs to license, secure and regularly replace live radioactive isotopes. Built on a distinctive dual-gimbaled gantry design, the ZAP-X system uses gyroscopic mobility to direct radiosurgical beams from hundreds of unique angles to precisely concentrate radiation on the tumor target. This pioneering approach supports the clinical objective of protecting healthy brain tissue and patient neuro-cognitive function, as well as enable future potential SRS re-treatments without the unnecessary risks associated with multi-purpose radiation delivery technologies. |
format | Online Article Text |
id | pubmed-8648181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86481812021-12-07 IL-1 SRS Without the Bunker: Introduction and Clinical Experience of ZAP-X Gyroscopic Radiosurgery Adler, John R Neurooncol Adv Supplement Abstracts Each year more than two million patients worldwide are potential candidates for SRS, yet due to the significant costs and complexities of historical delivery systems, only 150,000 patients currently receive such treatment. Japan Shonin-cleared in 2020, ZAP Surgical’s ZAP-X Gyroscopic Radiosurgery platform was designed to solve this challenge, and ultimately bring world-class SRS to more patients in more places. ZAP-X is recognized for being the first and only vault-free SRS delivery system, thereby typically eliminating the need for providers to build costly shielded radiation treatment rooms. Utilizing a modern linear accelerator to produce radiation, ZAP-X is also the first and only dedicated radiosurgery system to no longer require Cobalt-60 radioactive sources, thereby eliminating the significant costs to license, secure and regularly replace live radioactive isotopes. Built on a distinctive dual-gimbaled gantry design, the ZAP-X system uses gyroscopic mobility to direct radiosurgical beams from hundreds of unique angles to precisely concentrate radiation on the tumor target. This pioneering approach supports the clinical objective of protecting healthy brain tissue and patient neuro-cognitive function, as well as enable future potential SRS re-treatments without the unnecessary risks associated with multi-purpose radiation delivery technologies. Oxford University Press 2021-12-06 /pmc/articles/PMC8648181/ http://dx.doi.org/10.1093/noajnl/vdab159.000 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Supplement Abstracts Adler, John R IL-1 SRS Without the Bunker: Introduction and Clinical Experience of ZAP-X Gyroscopic Radiosurgery |
title | IL-1 SRS Without the Bunker: Introduction and Clinical Experience of ZAP-X Gyroscopic Radiosurgery |
title_full | IL-1 SRS Without the Bunker: Introduction and Clinical Experience of ZAP-X Gyroscopic Radiosurgery |
title_fullStr | IL-1 SRS Without the Bunker: Introduction and Clinical Experience of ZAP-X Gyroscopic Radiosurgery |
title_full_unstemmed | IL-1 SRS Without the Bunker: Introduction and Clinical Experience of ZAP-X Gyroscopic Radiosurgery |
title_short | IL-1 SRS Without the Bunker: Introduction and Clinical Experience of ZAP-X Gyroscopic Radiosurgery |
title_sort | il-1 srs without the bunker: introduction and clinical experience of zap-x gyroscopic radiosurgery |
topic | Supplement Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648181/ http://dx.doi.org/10.1093/noajnl/vdab159.000 |
work_keys_str_mv | AT adlerjohnr il1srswithoutthebunkerintroductionandclinicalexperienceofzapxgyroscopicradiosurgery |